Company news
Co-Diagnostics, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Co-Diagnostics Announces Closing of $4.2 Million Registered Direct Offering Priced At-the-Market
March 1, 2020
Co-Diagnostics Announces $4.2 Million Registered Direct Offering Priced At-the-Market
February 26, 2020
Co-Diagnostics, Inc. Receives CE Mark for Novel Coronavirus Test
February 23, 2020
Co-Diagnostics Completes Submission of CE Marking Registration for COVID-19 Coronavirus Test
February 19, 2020
Co-Diagnostics Announces New Vector Control Orders and Continued Progress Toward Regulatory Clearance for Coronavirus Test
February 18, 2020
Co-Diagnostics Announces $10.2 Million Registered Direct Offering Priced At-the-Market
February 10, 2020
Co-Diagnostics, Inc. Announces Sales of New Coronavirus Test
February 9, 2020
Co-Diagnostics, Inc. Announces Launch of Test for New Coronavirus
February 5, 2020
Co-Diagnostics, Inc. Announces Successful Initial Verification of Novel Coronavirus Test
January 30, 2020
Co-Diagnostics Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market
January 27, 2020
Co-Diagnostics Announces $5.0 Million Registered Direct Offering Priced At-the-Market
January 23, 2020
Co-Diagnostics, Inc. Designs Test for New Coronavirus Using CoPrimer™ Platform
January 22, 2020
Co-Diagnostics, Inc. Launches Vector Control Mosquito Test for EEE Virus
December 9, 2019
Co-Diagnostics JV CoSara Receives Indian Regulatory Approval for Five Diagnostic Assays
December 2, 2019
Co-Diagnostics, Inc. Reports Continued Sales Momentum for Q3 2019
November 12, 2019
Co-Diagnostics Expands Vector Control Marketing Nationwide
October 14, 2019
Co-Diagnostics, Inc. Adds to Menu of Molecular Vector Control Products
October 9, 2019
Co-Diagnostics, Inc. to Launch Vector Control Products into Midwest US at OPMA Conference
September 18, 2019
Calls
The 5 newest of 22 calls. Every call is listed under its year.
- Co-diagnostics (NASDAQ:CODX) Q2 2026 Earnings Call
Aug 13, 2026
Transcript - Co-diagnostics (NASDAQ:CODX) Q1 2026 Earnings Call
May 14, 2026
Transcript - Co-diagnostics (NASDAQ:CODX) Q4 2025 Earnings Call
Mar 31, 2026
Transcript - Co-diagnostics (NASDAQ:CODX) Q3 2025 Earnings Call
Nov 13, 2025
Transcript - Co-diagnostics (NASDAQ:CODX) Q2 2025 Earnings Call
Aug 14, 2025
Transcript
Decks
- Corporate Update (September 2026)
Corporate update · 14 slides · Sep 16, 2026
- Investor Presentation (2026)
Investor deck · 16 slides · 2026